Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

Axel Bex, Peter F.A. Mulders, Michael A.S. Jewett, +17

JAMA Oncology

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer

Thomas Powles, Irfan Kayani, Christian U. Blank, +12

Annals of Oncology

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

Viktor Grünwald, Pierre I. Karakiewicz, Sevil Bavbek, +15

European Journal of Cancer

UrologyOncologyGenitourinary CancerCancer ManagementCancer Treatment +4

Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma

Marnix H. Geukes Foppen, Dieta Brandsma, Christian U. Blank, +3

Annals of Oncology

Leptomeningeal MetastasesMelanomaImmunologyImmunotherapyMedicine +1

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

Axel Bex, Astrid A.M. van der Veldt, Christian U. Blank, +4

World Journal of Urology

Cytoreductive SurgeryUrologySurgical OncologyGenitourinary CancerMedicine +6

A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer

Thomas Powles, Irfan Kayani, Kevin Sharpe, +13

Annals of Oncology

UrologyGenitourinary CancerMedicineCancer GrowthProspective Evaluation +6

Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx).

Axel Bex, Yasmin Abu‐Ghanem, Johannes V. van Thienen, +11

Journal of Clinical Oncology

Surgical OncologyImmunologyImmunotherapeuticsSequential TissueGenitourinary Cancer +18

Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)

Roderick E. de Bruijn, Peter F.A. Mulders, Michael A.S. Jewett, +17

European Urology

UrologySurgical OncologyControlled TrialMedicineSurgical Pathology +5

Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report.

Charles B.L.M. Majoie, Erik M. Akkerman, Christian U. Blank, +3

PubMed

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor–targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data

Roderick de Bruijn, Akhila Wimalasingham, Bernadett Szabados, +9

European Urology Oncology

UrologySurgical OncologyGenitourinary CancerMedicineRenal Pathology +5